Open a GHK-Cu serum or a vial of the powder and you'll see a blue to violet color. People ask whether it's supposed to look like that, and whether a paler or clearer product is fake. The first answer is yes: copper peptides are blue [3]. The second is harder, because color is a weak test. This page explains where the blue comes from, what it can and can't tell you, and why storage depends on which of three very different products you hold.
Short answer: the copper does it
GHK is a tripeptide: glycine, histidine and lysine. GHK-Cu is that peptide holding one copper(II) ion. Copper(II) bound this way absorbs part of visible light, and the light it leaves behind is what you see.
The basics of the compound, its evidence and its status are on the GHK-Cu page.
How the peptide holds the copper
In solution, GHK grips copper(II) through three nitrogen atoms [1]. One is on the peptide's starting amino group, one is in its backbone, and one is in the ring of the histidine. A fourth position around the copper is held loosely by water or another nearby molecule, and it can swap.
That loose fourth position matters later. It means the copper's surroundings can change without the peptide changing, and the color can shift with them.
The copper complex absorbs part of visible light
A primary chemistry experiment measured a GHK-Cu absorption band at 606 nanometers; adding glutathione changed both intensity and the peak position [2]. These are controlled laboratory spectra, not a universal color specification for finished cosmetics.
Stronger color usually means more copper complex in the liquid. One formulation study noted that the amount of copper peptide "can be estimated by the hue" [3]. Estimated is the key word.
Is GHK-Cu supposed to be blue? What the color can and can't tell you
In a chemically characterized GHK-Cu sample, the color reflects its copper complex. In a finished unknown product, color cannot identify the source: other copper complexes, ingredients or dyes can also affect appearance. It does not measure intact peptide, concentration or sterility.
Two lab findings show both sides. When glutathione, a common reducing agent, reacts with GHK-Cu, the band weakens as the copper is reduced [2]. So a fading color can signal a real chemical change. In an experimental skin-delivery liquid, by contrast, the color turned "significantly lighter" while tests showed the peptide's structure was unchanged [3]. So a paler color doesn't by itself mean a product has gone bad.
| Question | Can the color answer it? |
|---|---|
| Does an unknown blue product necessarily contain GHK-Cu? | No; appearance is not chemical identification |
| Is intact GHK bound to the copper? | No |
| How much peptide is there? | No reliable visual concentration measurement across different formulations |
| Is it sterile? | No |
| Has it degraded? | Sometimes a change shows that something changed. No change proves nothing |
Does GHK-Cu need to be refrigerated? It depends on what you have
There is no FDA-approved GHK-Cu drug, so there is no FDA drug label setting storage. What you follow depends on which of three products you have.
| Product | How FDA treats it | Who sets storage | Status in the US |
|---|---|---|---|
| Cosmetic serum or cream | Cosmetics generally do not need premarket approval, except certain color additives [7] | The product's own label | Sold as a cosmetic, without drug claims |
| Compounded topical, by prescription | 503A Category 1, under evaluation, since May 14, 2026 [4] | The dispensing pharmacy's label, with a beyond-use date | Conditional interim policy, not product approval [5] |
| Injectable vial | Excluded from the non-injectable Category 1 entry [6] | No general storage rule established here | A seller label does not establish authorized supply or safe storage |
A prescription compound needs the dispensing pharmacy’s exact instructions and beyond-use date. Do not borrow storage rules from another cream, a chemical experiment or an unrelated injection. The topical evidence review explains why product formulation also matters when judging benefit.
Why injectable GHK-Cu is a different story
FDA says compounded injectable GHK-Cu "may pose risk for immunogenicity due to the potential for aggregation and peptide-related impurities," and that there are limited human data to judge its safety [6]. When FDA moved the compound into Category 1 in May 2026, it kept injectable routes out [4].
In 2025, one manufacturer's GHK-Cu for injection was recalled in all strengths for "lack of assurance of sterility," a recall FDA classified as Class II [8]. A vial that looks the right shade of blue can still be one of those. The routes are compared in GHK-Cu topical vs injected, the injectable's status is on injectable GHK-Cu, and the risks are on is GHK-Cu safe and is GHK-Cu FDA approved.
Each provider check on this site reads who prescribes and which pharmacy fills the order. See how we check.